AKT1 and urinary bladder cancer: Angiogenin (ANG) interacted with ribonuclease inhibitor and ANG up-regulation activated phosphorylation of key downstream target molecules of PI3K/AKT/mTOR signaling pathway, leading to the promotion of tumor angiogenesis, tumorigenesis and metastasis in bladder cancer cells [6].